(Q26864272)

language of work or name

1 reference

August 2013

1 reference

Alimentary Pharmacology & Therapeutics

published in

1 reference

volume

38

1 reference

issue

4

1 reference

page(s)

343-64

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

cites work

1 reference

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

21 January 2018

1 reference

Difficult treatment decisions in autoimmune hepatitis

21 January 2018

1 reference

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis in diverse ethnic populations and geographical regions

21 January 2018

1 reference

Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials

21 January 2018

1 reference

Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis.

21 January 2018

1 reference

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis

21 January 2018

1 reference

Autoimmune acute liver failure: proposed clinical and histological criteria

21 January 2018

1 reference

Autoimmune hepatitis with incidental histologic features of bile duct injury.

21 January 2018

1 reference

Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis

21 January 2018

1 reference

Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis

21 January 2018

1 reference

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.

21 January 2018

1 reference

Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis.

21 January 2018

1 reference

Acute and acute severe (fulminant) autoimmune hepatitis

21 January 2018

1 reference

Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis

21 January 2018

1 reference

The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants

21 January 2018

1 reference

Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.

21 January 2018

1 reference

Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature.

21 January 2018

1 reference

Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.

21 January 2018

1 reference

An unusual form of autoimmune hepatitis in young Somalian men.

21 January 2018

1 reference

Autoimmune hepatitis in the Indian subcontinent: 7 years experience

21 January 2018

1 reference

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

21 January 2018

1 reference

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin

21 January 2018

1 reference

Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis

21 January 2018

1 reference

Predictors of outcome in acute-on-chronic liver failure in children.

21 January 2018

1 reference

Autoimmune hepatitis in African Americans: presenting features and response to therapy

21 January 2018

1 reference

The impact of ethnicity on the natural history of autoimmune hepatitis

21 January 2018

1 reference

The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis.

21 January 2018

1 reference

Chronic liver disease in the Hispanic population of the United States

21 January 2018

1 reference

Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition

21 January 2018

1 reference

Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

21 January 2018

1 reference

Primary biliary cirrhosis

21 January 2018

1 reference

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

Drug-induced autoimmune-like hepatitis

21 January 2018

1 reference

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

21 January 2018

1 reference

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

21 January 2018

1 reference

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

21 January 2018

1 reference

Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome.

21 January 2018

1 reference

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

21 January 2018

1 reference

Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging

21 January 2018

1 reference

Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms

21 January 2018

1 reference

Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients

21 January 2018

1 reference

Immunosuppressive drugs: the first 50 years and a glance forward

21 January 2018

1 reference

Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety

21 January 2018

1 reference

Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications

21 January 2018

1 reference

Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines

21 January 2018

1 reference

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

21 January 2018

1 reference

Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease

21 January 2018

1 reference

Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine

21 January 2018

1 reference

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

21 January 2018

1 reference

Clinical pharmacology and pharmacogenetics of thiopurines

21 January 2018

1 reference

Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate

21 January 2018

1 reference

Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine

21 January 2018

1 reference

Use of laboratory testing to guide 6-mercaptopurine/azathioprine therapy

21 January 2018

1 reference

Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

21 January 2018

1 reference

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

21 January 2018

1 reference

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission

21 January 2018

1 reference

Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy

21 January 2018

1 reference

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

21 January 2018

1 reference

Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis

21 January 2018

1 reference

Advances in the current treatment of autoimmune hepatitis

21 January 2018

1 reference

Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.

21 January 2018

1 reference

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

21 January 2018

1 reference

Autoimmune hepatitis: focusing on treatments other than steroids

21 January 2018

1 reference

Inhibitors of the calcineurin/NFAT pathway.

21 January 2018

1 reference

Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.

21 January 2018

1 reference

Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis

21 January 2018

1 reference

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

21 January 2018

1 reference

Short-term cyclosporine induces a remission of autoimmune hepatitis in children.

21 January 2018

1 reference

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

21 January 2018

1 reference

Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis

21 January 2018

1 reference

De novo autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

Biochemical mechanisms of cyclosporine neurotoxicity

21 January 2018

1 reference

Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation.

21 January 2018

1 reference

Mycophenolate mofetil and its mechanisms of action

21 January 2018

1 reference

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy

21 January 2018

1 reference

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

21 January 2018

1 reference

Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.

21 January 2018

1 reference

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

21 January 2018

1 reference

A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis

21 January 2018

1 reference

Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.

21 January 2018

1 reference

Mycophenolate mofetil for autoimmune hepatitis: a single practice experience

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy

21 January 2018

1 reference

Drug choices in autoimmune hepatitis: part B--Nonsteroids

21 January 2018

1 reference

Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.

21 January 2018

1 reference

Cost-effectiveness of pharmacotherapy for autoimmune hepatitis

21 January 2018

1 reference

Drug choices in autoimmune hepatitis: part A--Steroids

21 January 2018

1 reference

Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis

21 January 2018

1 reference

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

21 January 2018

1 reference

Budesonide in previously untreated autoimmune hepatitis.

21 January 2018

1 reference

Budesonide induces complete remission in autoimmune hepatitis

21 January 2018

1 reference

Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience

21 January 2018

1 reference

Antiproliferative and apoptotic potencies of glucocorticoids: nonconcordance with their antiinflammatory and immunosuppressive properties

21 January 2018

1 reference

Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC.

21 January 2018

1 reference

Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome.

21 January 2018

1 reference

Rapidity of treatment response and outcome in type 1 autoimmune hepatitis

21 January 2018

1 reference

Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study

21 January 2018

1 reference

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

21 January 2018

1 reference

Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites.

21 January 2018

1 reference

Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma

21 January 2018

1 reference

Management and outcome of pregnancy in autoimmune hepatitis

21 January 2018

1 reference

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study

21 January 2018

1 reference

Pregnancy in autoimmune hepatitis: outcome and risk factors

21 January 2018

1 reference

Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?

21 January 2018

1 reference

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

21 January 2018

1 reference

Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy

21 January 2018

1 reference

A gender gap in autoimmunity.

21 January 2018

1 reference

Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery

21 January 2018

1 reference

Hepatocellular carcinoma in autoimmune hepatitis

21 January 2018

1 reference

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.

21 January 2018

1 reference

Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis

21 January 2018

1 reference

Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

21 January 2018

1 reference

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

21 January 2018

1 reference

Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

21 January 2018

1 reference

α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.

21 January 2018

1 reference

Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

21 January 2018

1 reference

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma

21 January 2018

1 reference

Randomized controlled trial of screening for hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

21 January 2018

1 reference

Utilization of screening for hepatocellular carcinoma in the United States.

21 January 2018

1 reference

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States

21 January 2018

1 reference

Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States

21 January 2018

1 reference

Screening for liver cancer: the rush to judgment.

21 January 2018

1 reference

'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?

21 January 2018

1 reference

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

21 January 2018

1 reference

Increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment

21 January 2018

1 reference

Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12381

0 references

PubMed publication ID

23808490

1 reference